Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes Schmid

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Inflammation (London, England)|January 7, 2016
CXCL14 as an emerging immune and inflammatory modulatorJing Lu, Mita Chatterjee, Hannes Schmid, et al.
Plos Genetics|May 6, 2017
Hairless-binding deficient Suppressor of Hairless alleles reveal Su(H) protein levels are dependent on complex formation with HairlessHeiko Praxenthaler, Anja C Nagel, Adriana Schulz, et al.
Frontiers in Cell and Developmental Biology|May 3, 2021
Phospho-Site Mutations in Transcription Factor Suppressor of Hairless Impact Notch Signaling Activity During Hematopoiesis in <i>Drosophila</i>Lisa Frankenreiter, Bernd M Gahr, Hannes Schmid, et al.
Frontiers in Immunology|August 22, 2018
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate LeukemiaHannes Schmid, Corina Schneidawind, Simona Jahnke, et al.
Cancers|May 28, 2020
MAT2A as Key Regulator and Therapeutic Target in <i>MLL</i>r LeukemogenesisKathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler, et al.
Oncogene|August 17, 2019
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr-Stoerzer, et al.
Arthritis Research & Therapy|April 2, 2020
Inhibition of effector B cells by ibrutinib in systemic sclerosisJakob Einhaus, Ann-Christin Pecher, Elisa Asteriti, et al.
Haematologica|January 14, 2021
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cellsHannes Schmid, Emmanuelle M Ribeiro, Kathy-Ann Secker, et al.
Arthritis Research & Therapy|October 17, 2019
Invariant natural killer T cells are functionally impaired in patients with systemic sclerosisAnn-Christin Pecher, Felix Kettemann, Elisa Asteriti, et al.
Frontiers in Immunology|July 30, 2019
Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote <i>ex vivo</i> Lysis of Leukemic Blasts in a CD1d-Dependent MannerSimona Jahnke, Hannes Schmid, Kathy-Ann Secker, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Inflammation (London, England)|January 7, 2016
CXCL14 as an emerging immune and inflammatory modulatorJing Lu, Mita Chatterjee, Hannes Schmid, et al.
Plos Genetics|May 6, 2017
Hairless-binding deficient Suppressor of Hairless alleles reveal Su(H) protein levels are dependent on complex formation with HairlessHeiko Praxenthaler, Anja C Nagel, Adriana Schulz, et al.
Frontiers in Cell and Developmental Biology|May 3, 2021
Phospho-Site Mutations in Transcription Factor Suppressor of Hairless Impact Notch Signaling Activity During Hematopoiesis in <i>Drosophila</i>Lisa Frankenreiter, Bernd M Gahr, Hannes Schmid, et al.
Frontiers in Immunology|August 22, 2018
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate LeukemiaHannes Schmid, Corina Schneidawind, Simona Jahnke, et al.
Cancers|May 28, 2020
MAT2A as Key Regulator and Therapeutic Target in <i>MLL</i>r LeukemogenesisKathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler, et al.
Oncogene|August 17, 2019
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr-Stoerzer, et al.
Arthritis Research & Therapy|April 2, 2020
Inhibition of effector B cells by ibrutinib in systemic sclerosisJakob Einhaus, Ann-Christin Pecher, Elisa Asteriti, et al.
Haematologica|January 14, 2021
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cellsHannes Schmid, Emmanuelle M Ribeiro, Kathy-Ann Secker, et al.
Arthritis Research & Therapy|October 17, 2019
Invariant natural killer T cells are functionally impaired in patients with systemic sclerosisAnn-Christin Pecher, Felix Kettemann, Elisa Asteriti, et al.
Frontiers in Immunology|July 30, 2019
Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote <i>ex vivo</i> Lysis of Leukemic Blasts in a CD1d-Dependent MannerSimona Jahnke, Hannes Schmid, Kathy-Ann Secker, et al.
Pageof 2